Extensive Product Profile: Understanding Tamorel (Tamoxifen Citrate 20 mg) Tamorel, containing 20 mg of tamoxifen citrate, is a non-steroidal selective estrogen receptor modulator (SERM). It is widely utilized in oncology for its ability to selectively bind to estrogen receptors, acting as an antagonist in breast tissue while exhibiting estrogenic agonist effects in other parts of the body, such as the bones and uterus. 1. Clinical Indications & Usage Breast Cancer Treatment: It is indicated for the treatment of metastatic breast cancer and as adjuvant therapy for node-positive or node-negative breast cancer following surgery and radiation. Breast Cancer Prevention: Used for the primary prevention of invasive breast cancer in women at moderate or high risk, and to reduce the risk of invasive breast cancer in women with Ductal Carcinoma in Situ (DCIS). Anovulatory Infertility: Utilized to induce ovulation in women with anovulatory cycles. Other Conditions: Occasionally used off-label for conditions such as McCune-Albright syndrome, gynecomastia, and certain metastatic cancers. 2. Mechanism of Action Estrogen Receptor Modulation: It competes with estrogen for binding sites on estrogen receptors. Antitumor Effect: In breast tissue, it exerts anti-estrogenic activity, blocking the signals required for the growth and multiplication of hormone receptor-positive cancer cells. Tissue-Specific Agonism: In other tissues like bone, it acts as an estrogen agonist, helping to maintain bone mineral density and potentially reducing the risk of osteoporosis in postmenopausal women. 3. Administration and Dosing Route: Tamorel 20 mg is an oral tablet formulation. Standard Schedule: The recommended daily dose for breast cancer is typically 20 mg. For infertility, dosing is specific to the menstrual cycle and may be adjusted by a physician. Consistency: Tablets should be taken at the same time each day, with or without food. ⚠️ Safety, Side Effects, and Monitoring Common Side Effects: Frequently reported effects include hot flashes, vaginal discharge, menstrual irregularities, fatigue, and mood changes. Serious Risks: There is an increased risk of thromboembolic events (DVT, pulmonary embolism, stroke) and uterine malignancies, including endometrial cancer. Monitoring: Periodic blood counts, liver function tests, and gynecological examinations are recommended. Patients should immediately report any unusual vaginal bleeding, pelvic pain, or respiratory distress. 📦 Storage and Handling Specifications Storage: Store in a dry, cool place below 30°C, protected from light and moisture. Safety: Keep out of reach of children. WHY CHOOSE ERNEST IMPEX Reliable Global Compliance Specialized Pharmaceutical Expertise PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is for educational purposes. Tamoxifen must be used only under the direct guidance of a registered oncology specialist. Use is contraindicated during pregnancy and breastfeeding, as it may cause fetal harm. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com | www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383